SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$643M
AUM Growth
+$316M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$95.4M
2
+$41.2M
3
+$24.6M
4
ABVX
Abivax
ABVX
+$9.1M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$7.05M

Top Sells

1
+$11.9M
2
+$8.52M
3
+$7.94M
4
IMCR icon
Immunocore
IMCR
+$4.2M
5
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$3.45M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$128M 19.85%
6,788,609
+2,189,781
2
$115M 17.85%
1,845,948
3
$95.4M 14.84%
+4,121,689
4
$38.9M 6.05%
4,519,361
5
$25.6M 3.98%
460,441
-153,480
6
$24.6M 3.82%
+1,267,790
7
$22.2M 3.45%
1,208,473
8
$18.9M 2.94%
2,868,035
9
$18.8M 2.93%
2,523,022
+141,443
10
$15.2M 2.36%
1,458,875
11
$14.6M 2.27%
55,605
12
$13.9M 2.16%
1,786,427
+904,977
13
$13.7M 2.13%
967,527
14
$12.8M 2%
799,274
15
$9.1M 1.41%
+850,000
16
$7.94M 1.23%
172,647
-172,646
17
$7.19M 1.12%
1,675,579
18
$6.91M 1.07%
347,500
19
$6.84M 1.06%
3,640,015
20
$6.66M 1.04%
1,562,500
21
$6.24M 0.97%
630,000
22
$5.59M 0.87%
6,130,268
23
$4.17M 0.65%
396,000
24
$4.17M 0.65%
470,304
25
$3.87M 0.6%
360,414
1
2